Speakers


Keynote Speakers

Kate Bingham

Kate Bingham

Read more

Managing Director, SV Health Investors | Chair, UK Vaccine Taskforce (Until January 2021)

John Reed, M.D., Ph.D.

John Reed, M.D., Ph.D.

Read more

Executive Vice President, Global Head of Research & Development, Sanofi

Moncef Slaoui

Moncef Slaoui

Read more

Partner, Medicxi | The scientific head of Operation Warp Speed

Conference Speakers & Panelists

Isaac Chang

Isaac Chang

Read more

Morningside Ventures

Francesco De Rubertis

Francesco De Rubertis

Read more

Co-founder and Partner, Medicxi

Carol Gallagher

Carol Gallagher

Read more

Partner, New Enterprise Associates, Inc. (NEA)

Henry Gosebruch

Henry Gosebruch

Read more

Executive Vice President and Chief Strategy Officer, AbbVie

Sheila Gujrathi, M.D.

Sheila Gujrathi, M.D.

Read more

Co-Founder, Chief Executive Officer, Gossamer Bio

Jason Hafler

Jason Hafler

Read more

Managing Director, Sanofi Ventures

Reza Halse

Reza Halse

Read more

President, Merck Research Labs Ventures Fund

Faheem Hasnain

Faheem Hasnain

Read more

Executive Advisor, Vertex Ventures

Richard Heyman

Richard Heyman

Read more

Executive Chairman and Co-founder, Metacrine Inc.

Nina Kjellson

Nina Kjellson

Read more

General Partner/West Coast, Canaan

Angele Maki, PhD

Angele Maki, PhD

Read more

Vice President of Emerging Technology & Innovation, Eli Lilly

Carole Nuechterlein

Carole Nuechterlein

Read more

Head, Roche Venture Fund

Heather Preston

Heather Preston

Read more

Managing Partner, Pivotal

Ioannis Sapountzis, PhD

Ioannis Sapountzis, PhD

Read more

Corporate Senior Vice President, Business Development, Boehringer Ingelheim Pharmaceuticals, Inc.

Uwe Schoenbeck, PhD

Uwe Schoenbeck, PhD

Read more

Senior Vice President and Chief Scientific Officer, Emerging Science and Innovation (ES&I), Pfizer Worldwide Research, Development, and Medical

Andrew Schwab

Andrew Schwab

Read more

Founder & Managing Partner, 5AM Ventures

Armen Shanafelt, Ph.D.

Armen Shanafelt, Ph.D.

Read more

General Partner, Lilly Ventures

Nigel Sheail

Nigel Sheail

Read more

Global Head, Mergers & Acquisitions and Business Development & Licensing, Novartis

Alex Szidon, PhD

Alex Szidon, PhD

Read more

Vice President and Head of Business Development, gRED at Genentech

Ben Thorner

Ben Thorner

Read more

Senior Vice President, Business Development and Licensing, Merck Research Laboratories

Jeffrey Warmke, PhD

Jeffrey Warmke, PhD

Read more

Senior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo